Background Little is known about the effects of continued antiplatelet therapy in patients who
receive physician home visits. This study aimed to evaluate the association of survival with …

Objective Despite the frequent use of antiplatelet medication (AM) in the elderly patients,
very few studies have investigated its prescription. We describe AM prescription through …

Background The use of antiplatelet agents is strongly recommended for the secondary
prevention of ischemic events such as myocardial infarction, stroke/transient ischemic attack …

Objectives This study aimed to evaluate the prescription patterns of drugs during the last
year of life in homebound older adults who received home medical care. Methods We used …

Background: Physician home visits are associated with better health outcomes, yet most
patients near the end of life never receive such a visit. Our objectives were to describe the …

Background Polypharmacy increases the risk of potentially inappropriate prescribing.
STOPP&START criteria identify a group of drugs representing inappropriate medication and …

Background Japan has the most rapidly ageing population in the world. The Japanese
government has, therefore, promoted physician-led home health care for frail and disabled …

This case study reviews appropriate antiplatelet treatment options for an older patient post-
myocardial infarction and stent placement. This case investigates the benefits and risks …

To assess the conditions of prescriptions and tolerance of antiplatelet drugs (APD) in the
elderly and to detail the parameters that influence the tolerance of these drugs. Prospective …

Context: Home visits at the end of life decrease hospitalizations and hospital deaths, which
reduces healthcare costs and aligns with most patients' wishes. In addition to family …